{
    "clinical_study": {
        "@rank": "163143", 
        "arm_group": [
            {
                "arm_group_label": "Active FNB, placebo ACB", 
                "arm_group_type": "Experimental", 
                "description": "FNB with 30 ml of ropivacaine 0,2% and ACB with 30 ml of placebo (saline). The ACB will be performed just prior to the FNB. The blockades will be performed just after obtaining the baseline values (outcome measures) at time 0."
            }, 
            {
                "arm_group_label": "Active ACB, placebo FNB", 
                "arm_group_type": "Experimental", 
                "description": "ACB with 30 ml of ropivacaine 0,2% and FNB with 30 ml of placebo (saline.The ACB will be performed just prior to the FNB. The blockades will be performed just after obtaining the baseline values (outcome measures) at time 0."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare the effect of a Adductor Canal Blockade (ACB) vs a\n      Femoral Nerve Blockade (FNB), on muscle strength, mobility and pain in patients with severe\n      pain (VAS pain score > 60) after Total Knee Arthroplasty (TKA."
        }, 
        "brief_title": "Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain After TKA", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Mobility After Total Knee Arthroplasty", 
        "detailed_description": {
            "textblock": "The patients will be included after surgery (the first 2 postoperative days). Patients\n      reporting VAS > 60 during active flexion of the knee can be included. All included patients\n      will receive 2 blockades at the same time - an ACB and a FNB, one blockade with 30ml\n      ropivacaine 0,2% and the other with 30ml saline according to randomization.\n\n      Prior to, and after, the blockades VAS pain scores will be obtained, muscle strength\n      (quadriceps and adductors) will be measured using a handheld dynanometer and a Timed Up and\n      Go test will be performed.\n\n      The study is registered at clinicaltrials.gov after inclusion of the first patient. The\n      reason for this is that we recently became aware of that some journals do not accept a\n      EudraCT registration. The study was registered at EudraCT (2012-004554-28)prior to\n      enrollment of patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  TKA within 72 hours and VAS>60 during 45 degrees active flexion of the knee despite\n             conventional pain medication\n\n          -  informed consent\n\n          -  ASA 1-3\n\n          -  BMI 18-40\n\n        Exclusion Criteria:\n\n          -  Unable to communicate in Danish\n\n          -  Allergic reactions toward ropivacaine\n\n          -  Alcohol and or drug abuse\n\n          -  Unable to cooperate\n\n          -  Known sensory disturbances in the lower limbs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01922596", 
            "org_study_id": "SM3_UG_12", 
            "secondary_id": "2012-004554-28"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Active FNB, placebo ACB", 
                    "Active ACB, placebo FNB"
                ], 
                "intervention_name": "Ropivacaine", 
                "intervention_type": "Drug", 
                "other_name": "Naropin"
            }, 
            {
                "arm_group_label": [
                    "Active FNB, placebo ACB", 
                    "Active ACB, placebo FNB"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Saline"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Total Knee Arthroplasty", 
            "Adductor Canal Blockade", 
            "Us-guided nerve blockade"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Gentofte Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain in Patients With Severe Pain After Total Knee Arthroplasty", 
        "overall_official": {
            "affiliation": "Gentofte Hospital", 
            "last_name": "Ulrik Grevstad, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Ethics Committee", 
                "Denmark: National Board of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Maximum Voluntary Isometric Contraction (MVIC) of the quadriceps femoris muscle will be measured before and 2 hours after the blockade. The change will be compared between the groups. At each measuring point three measurements will be made and the average of these used.", 
            "measure": "Change i muscle strength of the quadriceps muscle, after the blockade", 
            "safety_issue": "No", 
            "time_frame": "0 and 120 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01922596"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Gentofte, Copenhagen", 
            "investigator_full_name": "Ulrik Grevstad", 
            "investigator_title": "Consultant", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "MVIC of the adductors will be measured before and 2 hours after the blockades. The change will be compared between the groups. At each measuring point three measurements will be made and the average of these used.", 
                "measure": "muscle strength, adductor muscles", 
                "safety_issue": "No", 
                "time_frame": "0 and 120 minutes"
            }, 
            {
                "description": "The change in time to perform a TUG test before and after the blockades will be compared between the groups. Also the change in highest pain score during the TUG tests will be compared between the groups", 
                "measure": "Timed Up and Go (TUG)test", 
                "safety_issue": "No", 
                "time_frame": "0 and 120 minutes"
            }, 
            {
                "description": "VAS pain scores at rest will be obtained before VAS pain scores during passive flexion of the knee.\nThe change between groups will be compared", 
                "measure": "VAS pain scores at rest", 
                "safety_issue": "No", 
                "time_frame": "0 and 120 minutes"
            }, 
            {
                "description": "VAS pain scores during passive 45 degrees flexion of the knee. The change will be compared between the groups. VAS during passive flexion will be obtained prior to the MVIC measurements and the TUG test", 
                "measure": "Pain during passive flexion of the knee", 
                "safety_issue": "No", 
                "time_frame": "0 and 120 minutes"
            }
        ], 
        "source": "University Hospital, Gentofte, Copenhagen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Gentofte, Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}